Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
A closer listen to lion calls may help map where the big cat is under threat.
Scientists remain split on whether rope-pulling ingenuity counts as tool use.